| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |